Search research articles
Contact Us
Filters
Showing results (201-210 of 224) with videos related to
Page
of 23
Sort By:
JAMA Oncology
|
January 19, 2017
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525
Erica Hlavin Bell, Stephanie L Pugh, Joseph P McElroy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 19, 2018
Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
Himanshu R Lukka, Stephanie L Pugh, Deborah W Bruner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 7, 2020
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424
Barbara J Fisher, Stephanie L Pugh, David R Macdonald, et al.
JCO Precision Oncology
|
September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma
Jessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 13, 2024
Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial
Elizabeth A Hahn, Stephanie L Pugh, Hien L Lu, et al.
Plos One
|
April 14, 2021
Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415
Rahul Khairnar, Stephanie L Pugh, Howard M Sandler, et al.
The New England Journal of Medicine
|
February 2, 2017
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer
William U Shipley, Wendy Seiferheld, Himanshu R Lukka, et al.
JCO Clinical Cancer Informatics
|
May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials
Mack Roach, Jingbin Zhang, Osama Mohamad, et al.
Journal of Neuro-Oncology
|
November 11, 2021
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
Nirav Patil, Eashwar Somasundaram, Kristin A Waite, et al.
JCO Precision Oncology
|
July 8, 2026
Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology
Sophia C Kamran, Monica Borges, Jeff Michalski, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 224) with videos related to
Sort By:
Page
of 23
JAMA Oncology
|
January 19, 2017
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525
Erica Hlavin Bell, Stephanie L Pugh, Joseph P McElroy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 19, 2018
Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
Himanshu R Lukka, Stephanie L Pugh, Deborah W Bruner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 7, 2020
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424
Barbara J Fisher, Stephanie L Pugh, David R Macdonald, et al.
JCO Precision Oncology
|
September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma
Jessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 13, 2024
Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial
Elizabeth A Hahn, Stephanie L Pugh, Hien L Lu, et al.
Plos One
|
April 14, 2021
Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415
Rahul Khairnar, Stephanie L Pugh, Howard M Sandler, et al.
The New England Journal of Medicine
|
February 2, 2017
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer
William U Shipley, Wendy Seiferheld, Himanshu R Lukka, et al.
JCO Clinical Cancer Informatics
|
May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials
Mack Roach, Jingbin Zhang, Osama Mohamad, et al.
Journal of Neuro-Oncology
|
November 11, 2021
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
Nirav Patil, Eashwar Somasundaram, Kristin A Waite, et al.
JCO Precision Oncology
|
July 8, 2026
Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology
Sophia C Kamran, Monica Borges, Jeff Michalski, et al.
Page
of 23